Page 8 - Watson School News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: Apr 27, 2021     CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Repertoire Immune Medicines, a clinical-stage biotech company decoding the immune synapse to create novel immune therapies for cancer, immune disorders, infectious disease, and other serious diseases, today announced the company has elected neuroscience researcher and educator, Susan Hockfield, Ph.D., President Emerita of MIT, to its board of directors. John Cox, Chief Executive Officer, Board of Directors, Repertoire Immune Medicines “Dr. Hockfield is a tremendous addition to Repertoire Immune Medicines, as a scientist, ...

never been challenged in this way. >> reporter: edwards' attorney is expected to argue it can't be a campaign contribution when edwards never handled nor deposited the money into a campaign account. the government's star witness former aid andrew young is expected to testify edwards himself set up the hush fund though edwards says young pocketed a lot of the money. >> i think a central theme in this case is going to be one admitted liar against another. both sides anticipate at least a month-long trial where edwards might take the stand in his own defense. here most of us woke up t...